PRQR
ProQR Therapeutics BVNASDAQ
Healthcare • Biotechnology
Updated 18 hours ago
Coverage ready
Factor tilt: Anti-Quality Micro Cap
$1.47-0.68%
Close Oct 14, 2026
- Market cap
- $161.64M
- 1 month
- -20.1%
- 3 months
- -12.0%
- 1 year
- -35.8%
- 52-week range
- $1.37$3.05
- Dividend
- No dividends on record
- Short interest
- 3.1% of float2.9M shares · settled Sep 30, 2026 · +19.2% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if PRQR is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
29 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 73 days ago
Red flags: 1
Largest 13-F holders · Q2 2026
70 filers reported a long position in PRQR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $16.8M | 9M | +44.2% |
| Aberdeen Group plc | $16.6M | 8.9M | +169.3% |
| Affinity Asset Advisors, LLC | $10.3M | 5.5M | +125.9% |
| Privium Fund Management B.V. | $10.3M | 5.5M | +1% |
| Ikarian Capital, LLC | $6.4M | 3.4M | +129.6% |
| Woodline Partners LP | $6.1M | 3.3M | New |
| HEIGHTS CAPITAL MANAGEMENT, INC | $5.1M | 2.8M | New |
| MORGAN STANLEY | $3.3M | 1.8M | +36% |
| SPHERA FUNDS MANAGEMENT LTD. | $3.3M | 1.8M | New |
| Kynam Capital Management, LP | $2.9M | 1.6M | Unchanged |
Get the Full Analysis for PRQR
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.